To demonstrate the therapeutic potential and clinical relevance of targeting HSP70 in pancreatic cancer, we first analyzed the mRNA expression of HSP70 (HSPA1A) in different tumor types in comparison with their normal tissue counterparts using the Cancer Genome Atlas (TCGA) (https://www.cancer.gov/tcga). This evidence concerns the gene HSPA1A and pancreatic neoplasm.